Lifeloc Technologies, Inc. Announces Results of Study the Determining Risk of Subject to Subject Virus Transmission Through Their FC Series and L Series
July 16, 2020 at 06:02 am EDT
Share
Lifeloc Technologies, Inc. announced the results of a study aimed at determining risk of subject to subject virus transmission through their FC Series (Phoenix 6.0, EV30, FC20, etc.) and L Series (LX9, LT7, LT7I) breath alcohol testing products. The study, which was commissioned by Lifeloc, simulated a breath alcohol test performed on a highly infected test subject by pumping approximately 2 million MS2 Bacteriophage virus particles through a mouthpiece to simulate an infected subject. The MS2 virus was used in the study as a surrogate for common infectious viruses. After the highly infected test subject simulation, a following breath alcohol test was performed to evaluate risk of cross-contamination on test subjects. Analysis of the air pulled through multiple mouthpieces found no detectable viruses with the FC Series and L Series units. This analysis was done by an independent test laboratory familiar with testing bioactive hazard risks. Only Lifeloc-brand breath alcohol testers were examined and were demonstrated to not present this risk.
Lifeloc Technologies, Inc. is a manufacturer of evidential breath alcohol testers and related training and supplies for workplace, law enforcement, corrections, and international customers. The Company designs, produces and sells fuel-cell based breath alcohol testing equipment. It operates through two segments: Products and Rentals. The Products segment is engaged in the sale of physical products, including portable hand-held breathalyzers and related accessories, supplies, education, training, and royalties from development contracts with original equipment manufacturers (OEMs). The Rentals segment is engaged in the rental of a portion of its building. In addition, the Company offers a line of supplies, accessories, services, and training to support customers alcohol testing programs. It sells globally through distributors as well as directly to users. It sells certain of its components to customers for incorporation into their own product lines and for resale under their own name.
Lifeloc Technologies, Inc. Announces Results of Study the Determining Risk of Subject to Subject Virus Transmission Through Their FC Series and L Series